Cargando…
Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that often persists throughout life. Approximately two-thirds of patients with a childhood diagnosis of ADHD continue to experience clinically significant symptoms into adulthood. Nevertheless, most of these individuals...
Autor principal: | Goodman, David W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616744/ https://www.ncbi.nlm.nih.gov/pubmed/23576871 http://dx.doi.org/10.2147/TCRM.S30762 |
Ejemplares similares
-
The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder
por: Boesen, Kim, et al.
Publicado: (2017) -
Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
por: Iwanami, Akira, et al.
Publicado: (2020) -
Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
por: Iwanami, Akira, et al.
Publicado: (2020) -
A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4–5 Years with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2022) -
Adult attention-deficit/hyperactivity disorder and nicotine withdrawal: a qualitative study of patient perceptions
por: Liebrenz, Michael, et al.
Publicado: (2016)